{{Rsnum
|rsid=1379659
|Gene=SLIT2
|Chromosome=4
|position=20619060
|Orientation=plus
|GMAF=0.1345
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=SLIT2
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 69.6 | 26.8 | 3.6
| HCB | 78.2 | 18.8 | 3.0
| JPT | 73.9 | 24.3 | 1.8
| YRI | 100.0 | 0.0 | 0.0
| ASW | 94.7 | 5.3 | 0.0
| CHB | 78.2 | 18.8 | 3.0
| CHD | 73.8 | 23.4 | 2.8
| GIH | 69.7 | 27.3 | 3.0
| LWK | 98.2 | 1.8 | 0.0
| MEX | 71.9 | 28.1 | 0.0
| MKK | 86.3 | 13.7 | 0.0
| TSI | 58.0 | 39.0 | 3.0
| HapMapRevision=28
}}{{PMID|17903301|OA=1
}} Left ventricle diastolic dimension, [[rs1379659]] (SLIT2, p = 1.17*10(-7))

{{GWAS Summary
|SNP=rs1379659
|PubMedID=17903301
|Condition=Echocardiographic traits
|Gene=SLIT2
|Risk Allele=
|pValue=1.00E-007
|OR=NA
|95CI=
|OA=1
}}

{{PharmGKB
|RSID=rs1379659
|Name_s=
|Gene_s=SLIT2
|Feature=
|Evidence=PubMed ID:17903301; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS results: Genome-wide association of echocardiographic dimensions, brachial artery endothelial function and treadmill exercise responses in the Framingham Heart Study (Initial Sample Size: 1,238 individuals (Framingham); Replication Sample Size: NR). This variant is associated with Echocardiographic traits.
|Drugs=
|Drug Classes=
|Diseases=Cardiovascular Diseases
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA162356467
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs1379659
|overall_frequency_n=9208
|overall_frequency_d=10758
|overall_frequency=0.855921
|n_genomes=52
|n_genomes_annotated=0
|n_haplomes=92
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}